RJA
ASTH icon

Raymond James & Associates’s Astrana Health ASTH Stock Holding History

Raymond James & Associates’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,117
Closed -$376K – 4291
2021
Q4 		$376K Sell
5,117
-1,350
-21% -$111K ﹤0.01% 3300
2021
Q3 		$589K Buy
+6,467
New +$550K ﹤0.01% 2946

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Raymond James & Associates's ASTH Position: Q1 2022 in Review

Raymond James & Associates sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 5,117 shares — an estimated $376K sold.

Raymond James & Associates first reported a position in ASTH in Q3 2021 and held it in 2 quarters. The position peaked at $589K in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Raymond James & Associates reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 5,117 Astrana Health shares in Q1 2022, an estimated $376K.
  • Raymond James & Associates first reported a position in Astrana Health in Q3 2021 and held it in 2 quarters.
  • Raymond James & Associates's Astrana Health position peaked at $589K in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.